Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-161-6 | CAS number: 1229654-66-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 - 28 Mar 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted in 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted in 2008
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GYEMSZI National Institute for Quality- and Organizational Development in Healthcare and Medicines, Budapest, Hungary
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-1,2,3,4-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide
- EC Number:
- 810-161-6
- Cas Number:
- 1229654-66-3
- Molecular formula:
- C22 H16 Cl F3 N10 O2
- IUPAC Name:
- 1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-1,2,3,4-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J Rj
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier, Genest-St-Isle, France
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 10 weeks (main study), 11 weeks (preliminary experiment)
- Weight at study initiation: 20.3 - 21.7 g (main study), 20.5 - 22.8 g (preliminary experiment)
- Housing: groups in type II polypropylene/ polycarbonate cages, Lignocel® 3/4-FASERN Hygienic Animal Bedding (J. Rettenmaier & Söhne GmbH & Co.KG, Rosenberg, Germany), glass tunnel-tubes
- Diet: ssniff® SM Rat/Mouse (ssniff Spezialdiäten GmbH, Soest, Germany), ad libitum
- Water: tap water from the municipal supply, ad libitum
- Acclimation period: 20 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.5 - 24.8
- Humidity (%): 30 - 73
- Air changes (per hr): 15 - 20
- Photoperiod (hrs dark / hrs light):12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 25 and 50% (w/v) (preliminary irritation/toxicity test)
10, 25 and 50% (w/v) (main test) - No. of animals per dose:
- 2 (preliminary irritation/toxicity test)
4 (main test) - Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: The solubility of the test item was examined in a short preliminary compatibility test. Due to the physical characteristics of the test item, 100% concentration was not achievable. No proper formulation was achieved at 50% (w/v) concentration using acetone: olive oil 4:1 (v/v) mixture, N,N-dimethylformamide, methyl ethyl ketone, propylene glycol or 1% aqueous pluronic PE9200 as vehicle. However, the formulation at 50% (w/v) using dimethyl sulfoxide as vehicle was suitable for the test.
- Irritation: A preliminary irritation/toxicity test was conducted in 2 animals per dose at concentrations of 25 and 50% (w/v) in DMSO. The preliminary experiment was conducted in a similar experimental manner to the main study, but it was terminated on Day 6 and no radioactive proliferation assay was performed. All mice were observed daily for local irritation at the application site. Alopecia was observed in the 50% (w/v) dose group on Day 6. Test item precipitate was observed on the ears for the both animals in the 50% (w/v) group on Days 1-6 and in the 25% (w/v) dose group on Days 1-4. Rigid ears was observed in the 50% (w/v) dose group on Days 2-5, and in the 25% (w/v) dose group on Days 2-3 which may have been caused by test item remaining on the ears. No irritation was observed.
- Systemic toxicity: All mice were observed daily for any clinical signs of systemic toxicity. No mortality or clinical signs of systemic toxicity were observed.
- Ear thickness measurements: Ear thickness was measured using a thickness gauge on Day 1 (pre-dose), Day 3 (before treatment, approximately 48 h after the first dose) and Day 6. Additional quantification of the ear thickness was performed by ear punch weight determination after the euthanasia of the experimental animals. The revealing ear punch weights were over the historical control range which may have been caused by test item remaining on the ears.
- Erythema scores: No erythema was observed.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: tritiated thymidine (³HTdR) incorporation determined by beta-scintillation
- Criteria used to consider a positive response: The test item is regarded as a sensitizer if both of the following criteria are fulfilled: Exposure to at least one concentration of the test item resulted in an incorporation of ³HTdR at least 3-fold or greater than recorded in control mice, as indicated by the stimulation index and the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION: On Day 1, 25 µL of the test substance freshly diluted with DMSO was topically applied to the dorsal surface of each ear of each mouse. The application was repeated on Days 2 and 3. There was no treatment on Days 4, 5 and 6. On day 6 an intravenous injection of 250 µL phosphate buffered saline (PBS) containing approximately 20 µCi of ³HTdR was made into the tail vein of each experimental mouse. 5 h (± 30 min) later, the draining auricular lymph node of each ear was excised into PBS. A single cell suspension of pooled lymph node cells was prepared from each mouse and collected by gentle mechanical disaggregating of the lymph nodes through a cell strainer using the plunger of a disposable syringe. The cell strainer was washed with PBS. Pooled LNCs were washed twice via pelleting using centrifugation and resuspension in PBS. Pellets were resuspended in 5% trichloroacetic acid and precipitation was conducted overnight at 2 - 8°C. Following centrifugation pellets were resuspended in 5% trichloroacetic acid and dispersed by using an ultrasonic bath. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The positive control (25% (w/v) alpha-hexylcinnamaldehyde in DMSO) induced a significant lymphoproliferative response with a stimulation index value of 13.2. No mortality, cutaneous reactions or signs of toxicity were observed in the positive control group. Thus, the results of the positive control group demonstrated the appropriate performance of the assay.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.6
- Test group / Remarks:
- 10% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 3.4
- Test group / Remarks:
- 25% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 5.6
- Test group / Remarks:
- 50% (w/v)
- Key result
- Parameter:
- EC3
- Value:
- 21.7
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA: Appearance of the lymph nodes was normal in the 25 and 10% (w/v) dose groups and in the negative control group. Larger than normal lymph nodes were observed in the 50% (w/v) dose group and in the positive control group. The number of radioactive disintegrations per minute (DPM) were measured and corrected with the background DPM value consisting of 5% (w/v) TCA solution measurements. The results were expressed as DPN (DPM divided by the number of lymph nodes) and are shown in table 1.
DETAILS ON STIMULATION INDEX CALCULATION: The stimulation index was calculated by division of the DPN value of a treated group with the DPN value of the negative control group. The SI values for the respective treatment groups are shown in table 1.
EC3 CALCULATION: The calculation of the EC3 value was conducted by linear interpolation according to the equation: EC3 = c + [(3-d)/(b-d)] x (a-c), where the data points lying immediately above and below the SI value of 3 on the LLNA dose-response plot have the co-ordinates (a,b) and (c,d) respectively. The calculated EC3 value for the test substance is 21.7% (w/v).
CLINICAL OBSERVATIONS: No mortality or signs of systemic toxicity were observed during the study. There were no indications of any irritancy at the site of application. Alopecia was observed in the 50% (w/v) dose group on Days 2 - 6 and in the 25% (w/v) dose group on Days 3 - 6. Test item precipitate was observed on the ears for the animals in all treated group on Days 1 - 6. Rigid ears were observed in the 50% (w/v) dose group on Days 2 - 6.
BODY WEIGHTS: No treatment-related effects were observed on animal body weights.
Any other information on results incl. tables
Table 1: Results of the LLNA
Test group |
Measured DPM / group |
DPM |
Number of lymph nodes |
DPN |
Stimulation Index |
Background (5% (w/v) TCA) |
34 |
- |
- |
- |
- |
Vehicle control (DMSO) |
1610 |
1576.0 |
8 |
197.0 |
1.0 |
Test substance 50% (w/v) |
8925 |
8891.0 |
8 |
111.4 |
5.6 |
Test substance 25% (w/v) |
5427 |
5393.0 |
8 |
674.1 |
3.4 |
Test substance 10% (w/v) |
2522 |
2488.0 |
8 |
311.0 |
1.6 |
Positive control (25% HCA in DMSO) |
20873 |
20839.0 |
8 |
2604.9 |
13.2 |
TCA = trichloroacetic acid, HCA = alpha-Hexylcinnamaldehyde
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- CLP: Skin sens 1B, H317
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.